Restart Life Sciences Corp. (CSE:HEAL)
Canada
· Delayed Price · Currency is CAD 0.100
0.00 (0.00%)
Dec 3, 2025, 2:32 PM EST
Restart Life Sciences Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | - | - | - | - | - | 0.01 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | 59.51% | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Gross Profit | - | - | - | - | -0.01 | 0 | Upgrade
|
| Selling, General & Admin | 0.81 | 0.59 | 0.86 | 1.4 | 1.58 | 0.63 | Upgrade
|
| Research & Development | 0.01 | 0 | 0.07 | 0.12 | 0.86 | 0.05 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Operating Expenses | 1.28 | 0.63 | 1.21 | 1.85 | 2.8 | 1.58 | Upgrade
|
| Operating Income | -1.28 | -0.63 | -1.21 | -1.85 | -2.8 | -1.58 | Upgrade
|
| Interest & Investment Income | - | - | - | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.01 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | -0.03 | -0.02 | 0.14 | -0.04 | -0.22 | Upgrade
|
| EBT Excluding Unusual Items | -1.27 | -0.65 | -1.22 | -1.71 | -2.84 | -1.8 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.24 | -0.14 | - | - | 0.02 | -5.69 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.05 | 0.63 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.22 | 0.38 | - | -0.76 | 0.13 | -17.74 | Upgrade
|
| Pretax Income | -1.23 | 0.22 | -1.22 | -2.47 | -2.68 | -25.23 | Upgrade
|
| Net Income | -1.23 | 0.22 | -1.22 | -2.47 | -2.68 | -25.23 | Upgrade
|
| Net Income to Common | -1.23 | 0.22 | -1.22 | -2.47 | -2.68 | -25.23 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 15 | 15 | 14 | 11 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 16 | 15 | 14 | 11 | 5 | Upgrade
|
| Shares Change (YoY) | 86.21% | 9.79% | 7.47% | 22.91% | 117.20% | 59.88% | Upgrade
|
| EPS (Basic) | -0.04 | 0.01 | -0.08 | -0.18 | -0.24 | -4.93 | Upgrade
|
| EPS (Diluted) | -0.05 | 0.01 | -0.08 | -0.18 | -0.24 | -4.93 | Upgrade
|
| Free Cash Flow | -0.4 | -0.07 | -0.28 | -2.41 | -1.95 | -0.86 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.02 | -0.18 | -0.17 | -0.17 | Upgrade
|
| Gross Margin | - | - | - | - | - | 15.07% | Upgrade
|
| Operating Margin | - | - | - | - | - | -13782.54% | Upgrade
|
| Profit Margin | - | - | - | - | - | -219950.23% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -7466.27% | Upgrade
|
| EBITDA | -1.28 | -0.62 | -1.2 | -1.84 | -2.8 | -1.57 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| EBIT | -1.28 | -0.63 | -1.21 | -1.85 | -2.8 | -1.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.